We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Official Spells Out Do’s and Dont’s of Generic Drug Labeling Practices
FDA Official Spells Out Do’s and Dont’s of Generic Drug Labeling Practices
An FDA official is taking steps to clarify labeling requirements for generic drugmakers, as frequent deficiencies can lead to increased review cycles and labeling that differs from reference products.